[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

SI1843771T1 - Use of pyrimidylaminobenzamides for the treatment of diseases that respond to modulation of tie-2 kinase activity - Google Patents

Use of pyrimidylaminobenzamides for the treatment of diseases that respond to modulation of tie-2 kinase activity

Info

Publication number
SI1843771T1
SI1843771T1 SI200631195T SI200631195T SI1843771T1 SI 1843771 T1 SI1843771 T1 SI 1843771T1 SI 200631195 T SI200631195 T SI 200631195T SI 200631195 T SI200631195 T SI 200631195T SI 1843771 T1 SI1843771 T1 SI 1843771T1
Authority
SI
Slovenia
Prior art keywords
pyrimidylaminobenzamides
tie
respond
diseases
modulation
Prior art date
Application number
SI200631195T
Other languages
Slovenian (sl)
Inventor
Paul W Manley
Georg Martiny-Baron
Juergen Mestan
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Priority claimed from PCT/EP2006/000686 external-priority patent/WO2006079539A2/en
Publication of SI1843771T1 publication Critical patent/SI1843771T1/en

Links

SI200631195T 2005-01-28 2006-01-26 Use of pyrimidylaminobenzamides for the treatment of diseases that respond to modulation of tie-2 kinase activity SI1843771T1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US64789505P 2005-01-28 2005-01-28
US66240405P 2005-03-16 2005-03-16
PCT/EP2006/000686 WO2006079539A2 (en) 2005-01-28 2006-01-26 Use of pyrimidylaminobenzamides for the treatment of diseases that respond to modulation of tie-2 kinase activity
EP06706432A EP1843771B1 (en) 2005-01-28 2006-01-26 Use of pyrimidylaminobenzamides for the treatment of diseases that respond to modulation of tie-2 kinase activity

Publications (1)

Publication Number Publication Date
SI1843771T1 true SI1843771T1 (en) 2012-01-31

Family

ID=45531600

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200631195T SI1843771T1 (en) 2005-01-28 2006-01-26 Use of pyrimidylaminobenzamides for the treatment of diseases that respond to modulation of tie-2 kinase activity

Country Status (1)

Country Link
SI (1) SI1843771T1 (en)

Similar Documents

Publication Publication Date Title
HK1222537A1 (en) Liquid formulations for treatment of diseases or conditions
HK1215960A1 (en) Improved modalities for the treatment of degenerative diseases of the retina
HRP20150175T1 (en) Means and methods for the treatment of tumorous diseases
IL227841A0 (en) Dihydropteridinones for the treatment of cancer diseases
DE602006019838D1 (en) PIPERAZINE-SUBSTITUTED BENZOTHIOPHENE FOR THE TREATMENT OF MENTAL DISEASES
IL184934A0 (en) 4-oxoquinazoline-3-yl-benzamide derivatives for the treatment of cytokine diseases
IL190338A0 (en) Biphenyloxyacetic acid derivatives for the treatment of respiratory disease
EP1962869A4 (en) Treatment of respiratory diseases
HK1113319A1 (en) Use of docosahexaenoic triglycerides for the treatment of tumorous diseases
PL2234631T3 (en) Compounds and methods for the treatment of vascular disease
IL213703A (en) Compounds for the treatment of pain and other diseases
ZA200806095B (en) Means and methods for the treatment of tumorous diseases
PL1904060T3 (en) Use of phthalocyanine derivates for the non-photodynamic treatment of diseases
IL213606A0 (en) 1-amino-alkylcyclohexane derivatives for the treatment of inflamatory skin diseases
GB0523961D0 (en) The treatment of ophthalmic diseases
IL186286A0 (en) Use of calcitonin as combined treatment therapy for the management of inflammatory disease conditions
SI1843771T1 (en) Use of pyrimidylaminobenzamides for the treatment of diseases that respond to modulation of tie-2 kinase activity
ZA200606780B (en) Compounds for the treatment of diseases
EP1846013A4 (en) Treatment of skin diseases
GB0523964D0 (en) The treatment of ophthalmic diseases
GB0425054D0 (en) Formamide derivatives for the treatment of diseases
GB0523965D0 (en) The treatment of ophthalmic diseases
GB0523962D0 (en) The treatment of ophthalmic diseases
IL177531A0 (en) Compounds for the treatment of diseases
GB0425073D0 (en) Compounds for the treatment of diseases